CA9 and neoplasm: Xu, Ren, and co-workers reported albumin/sulfonamide-stabilized iron porphyrin metal-organic framework nanocomposites that target tumor hypoxia through accumulation in tumors overexpressing carbonic anhydrase IX [378].